About Us
Nanophysics & Beyond
Curadigm
The Management
Our Commitments
Healthcare Professionals
Scientific Publications
Patients
Patient Engagement
Investors
Corporate Presentation
Financial Calendar
Regulated Information
SEC Filings
Annual General Meetings
Shareholder Corner
Press Releases
Congresses & Events
Nanotalks
NBTXR3 Development
R&D Day
Our Expert Videos
Nanoblog
From Curie to Nano
Contact & Newsletter
Medical Device Vigilance – Pharmacovigilance
Medical Information
Join Us
Nous vous informons que ce site est conforme à la législation française actuelle sur les dispositifs médicaux.
Continuer
Rester sur la page
Scientific Clinical | Nanobiotix announces new results from pre-clinical immuno-oncology study at SITC 2019
Financial | Nanobiotix announces third quarter 2019 revenue
25 October 2019
Corporate | Nanobiotix receives the 2019 Prix Galien award for first-in-class Hensify
16 December 2019
Scientific Clinical | Nanobiotix announces new results from pre-clinical immuno-oncology study at SITC 2019
Published by
Julie Ficheux
on
12 November 2019
No translations available for this page
